Depression
May Originate
in Our Genes
(July 31, 2003) Once controversial, new
research increasingly backs the notion that the seeds
of depression lie in our genes. It's an insight that carries widespread
implications for everything from treatment to insurance coverage.
A decade of experience with new anti-depressant
drugs like Prozac has persuaded even the most staunchly Freudian of
mental-health providers that depression is strongly rooted in our personal
biology.
It has become accepted wisdom that some
of us are born inherently prone to periods
of dark and despondent feelings, no matter what our later life experiences,
while others are armed to be psychologically more resilient. Now, scientists
are increasingly confident that those biological differences are driven
by specific genes.
The new research paradigm beginning to emerge
aims to identify the potentially numerous and different genes
believed to be involved in depression. Scientists then hope to figure
out which of these genes play pivotal roles in a person's individual mental
makeup and how life experiences conspire to trigger the disease.
Indeed, identifying the precise genes at work in depression
has become one of the most sought after scientific prizes being pursued by
genome researchers, partly because of how widespread depression is. The World
Health Organization recently said depression is the fourth-leading cause of
disease burden, which is defined as years patients must live with a disability.
The WHO figures about 121 million people world-wide suffer from depression, and
it estimates that depression will become the primary cause of disease burden
world-wide by the year 2020.
Two studies reported this month help reinforce
this emerging depression dogma. One report, from an international team
led by University of Wisconsin researchers, offers reasons some people
may be psychologically sturdier than others. Another report, from researchers
at the University of Pittsburgh Medical Center, shows how scientists exploiting
sophisticated new gene-hunting techniques are unmasking the precise genes
that may help strengthen the argument that depression
is a gene-based condition.
Wisconsin scientists and colleagues in Great
Britain and New Zealand looked at how inheriting variations of one particular
gene affected people's susceptibility to depression. The gene,
called 5-HTT, is the focus of much scientific interest because it
helps regulate the action of serotonin, one of several chemical neurotransmitters
that carry signals between brain cells. Prozac-like drugs work by increasing
the amount of serotonin that resides in between such cells, a change that
apparently improves a person's ability to manage stressful feelings.
Recent research by the group and others found that some people
inherit at least one short version of the 5-HTT gene, while others carry two
longer versions. (Each of us inherits two copies of every gene, one from each
parent. It is believed the protein chemicals made by a gene are often
influenced by the makeup of both copies.)
Researchers looked at the mental-health
status of 847 adult New Zealanders who experienced four traumatic events,
such as a death, divorce or job loss, over a five-year period. They compared
the behavior of those with one or two copies of the short version of the
gene with those who had two copies of the long version. Only 17% of those
with two copies of the long variant were diagnosed
with depression, while 33% of those with the one or two of the short
variants became depressed. Indeed, double-short-gene people were three
times more likely to attempt or commit suicide than those with the long
version.
Researchers
in Pittsburgh used a different approach to unmask another susceptibility
gene. Led by George Zubenko, the group looked at the DNA recently collected
from 81 families in which a recurrent
and major form of depression had been identified over many years of
study. By scanning the family members' entire genome -- made easier because
of new gene-sequencing data resulting from the human genome project --
the scientists found 19 different genetic regions that may contain genes
involved in depression. The DNA sequences of those with a history of illness
were consistently different in the 19 regions than the DNA sequences from
the same areas taken from relatives who were disease free.
Unlike the gene-specific findings of the Wisconsin-led team,
the Pittsburgh research may take many years to resolve. That's because the
initial discovery suggests the disease may result from an interplay of some
still-mysterious genes that reside within the 19 different DNA sites, Dr.
Zubenko says.
However, Dr. Zubenko says, at least one gene, CREB1, by itself
might not affect mental health but may regulate the activity of many of the
other genes. Instead, Dr. Zubenko believes but has yet to prove, certain
versions of CREB1 control the function of the other genes that likely make one
more or less prone to depression and other mental-health maladies.
Like so many gene-based findings these days, the two new
reports must be confirmed by others. In both instances, it will be years before
the research leads to some practical applications. It may never make sense,
ethically or medically, to use these and other gene findings to identify who
among us is biologically at risk and who isn't.
But, right away, these studies indicate that genes are
strongly associated with depression. That, in itself, is causing a major shift
in how the disease is being studied. More and more, depression will be viewed
as a biology-based medical disease that happens to affect the mind, much as
diabetes affects the heart and kidneys, or arthritis affects the joints, rather
than a psychological lapse within an individual's control.
Finding the biological underpinnings of depression is likely
also to have a widespread impact on the economics of the disease. One of the
most controversial aspects of mental health is that insurance plans rarely
cover treatment for depression on the same basis as other health problems.
Advocates for improved mental-health coverage are certain to use these
scientific insights to argue that coverage ought to be more generous than it
currently is.
Source: Wall Street Journal, Michael Waldholz
top ~ next ~
send page to a
friend
HealthyPlace.com
Depression Center Links
home ~ site map ~
causes ~ types ~
people ~
living with
treatments ~ self-help ~ support ~ suicide ~ related
issues
|